Streetinsider.com's Hot Lunchtime Reads 06/13: (MYGN) (CLSN) (DOLE) (PFE)
The following is a list of notable articles to help get you through the lunch hour:
- Some Shareholders Think $12/Share for Dole (DOLE) is 'Bananas' -> Read this!
- Negative Celsion (CLSN) Blogger at it Again -> Read this!
- Gannett (GCI)/Belo (BLC) Deal Puts Peers in Spotlight -> Read this!
- Avoid REITS with Long-Term Bond-Like Leases – Analyst (VTR) (MPW) (EPR) (LXP) -> Read this!
- Intevac (IVAC) $27M Army Contract Corroborates 20% Photonics Growth Goal - Needham & Company -> Read this!
- Pfizer's (PFE) Germano: Company Still in 'Evaluation Process' on Possible Split -> Read this!
- Myriad (MYGN) Issues Response to Supreme Court Decision on Gene Patent -> Read this!
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SeaChange (SEAC) Announces an Agreement to be Acquired by Enghouse and Termination of Previously Announced Proposed Acquisition by Partner One
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Day One Biopharmaceuticals (DAWN) PT Raised to $33 at Needham
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!